Post-approval studies (Phase 4)Study completedNCT02213796
What this trial is testing
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
Who this might be right for
Initial Phase of Severe Sepsis and Septic Shock
Sutep Jaruratanasirikul 9